No co-administration of Ketek tab. with Ketoconazole.

The KFDA announced label changes for more than 100 products including Ketek (Telithromycin), which was instructed to add warnings of liver toxicity and no administration with Ketoconazole as a contra-indication.

The KFDA said on Feb. 1 that the total 98 products were instructed to change their labels with appropriate warnings as a result of assessing the safety informations for 5 products ...